ME Association Research Review: Post-Exertional Malaise (PEM) in ME/CFS and Long Covid Read More »
Research evidence shows that the presence of PEM cannot be disputed and is not due to inactivity or deconditioning.
ME Association Research Review: Mortality in ME/CFS Read More »
Malnutrition is the most serious life-threatening complication in those with ME/CFS, especially in very severe cases.
By Dr Katrina Pears 20 January 2023 To read the
New study confirming endothelial dysfunction in ME/CFS Read More »
Back in June 2021 we reported on a study by
Research Review – What are the current treatments being trialled for Long COVID? Read More »
This research summary reviews what we currently know about the treatments which are being investigated for Long Covid.
In this Expert View, Dr Abhijit Chaudhuri discusses central fatigue
A recent publication by Hoel et al. who carried out
The SARS-CoV-2 receptor angiotensin-converting enzyme 2 (ACE2) in Myalgic Encephalomyelitis/Chronic
A recent publication by Goebel et al. with research carried
MEA Research Review: Altered Endothelial Function in ME/CFS Blood Plasma Read More »
A recent publication by Blauensteiner et al. based in Austria
“This provides an explanation for the common observation that ME/CFS patients often report a sharp decrease in the number of colds and other viral infections they experience…”
People with severe M.E. demonstrate low levels of Creatine Phosphokinase in study using samples from ME Biobank.
MEA Summary Review: Low Dose Naltrexone (LDN) in ME/CFS | 02 December 2019 Read More »
We have updated this research review to include a new study from Finland.
MEA Summary Review: Differentiating Medical Uncertainty | 21 October 2019 Read More »
We take a closer look at recent research from America that highlights concerns over inappropriate and harmful labelling and advocates for medicine to adopt a more patient-centred approach to care.
MEA Summary Review: The Role of Mitochondria in ME/CFS | 13 July 2019 Read More »
This latest review looks at energy production, and the ongoing search for clues as to what might be causing problems in ME/CFS.
“There is little scientific credibility in the claim that the psycho-behavioural therapies should be primary treatments for this illness.”
We discuss what the new research means and how the Biobank contribution continues to evolve.
MEA Summary Review: Assessing PEM – The characteristic symptom of ME/CFS | 25 March 2019 Read More »
Latest research analysis is hoped will lead to a definitive definition and will ultimately provide a validated clinical assessment tool.
Abnormalities in energy production would seem to occur ‘upstream’ of the mitochondria.
Evidence could support the involvement of oxidative stress, inflammation and hypoxia in ME/CFS.
